RE: SAHPRA15 Jul 2021 09:43
You're missing the point of our Covid vax... AvidiMab gets validated the value of that is massive,,, new delivery gets validated again huge value there and revolutionary to ImmunoBody platform.... a delivery that mRNA players as in all the winners are going to be very interested in.... so there is a lot more value in that Covidity trial than it being a second gen race winner... which it could well be too if it gets the data and backing.